These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14685064)

  • 1. Drug resistance is uncommon in pregnant women with low viral loads taking zidovudine monotherapy to prevent perinatal HIV transmission.
    Larbalestier N; Mullen J; O'Shea S; Cottam F; Sabin CA; Chrystie IL; Welch J; Zuckerman M; Hay P; Rice P; Taylor GP; de Ruiter A
    AIDS; 2003 Dec; 17(18):2665-7. PubMed ID: 14685064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.
    Sitnitskaya Y; Rochford G; Rigaud M; Essajee S; Pollack H; Krasinski K; Borkowsky W
    Clin Infect Dis; 2001 Jul; 33(1):e3-7. PubMed ID: 11389511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
    Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival.
    Bardeguez AD; Shapiro DE; Mofenson LM; Coombs R; Frenkel LM; Fowler MG; Huang S; Sperling RS; Cunningham B; Gandia J; Maupin R; Zorrilla CD; Jones T; O'Sullivan MJ;
    J Acquir Immune Defic Syndr; 2003 Feb; 32(2):170-81. PubMed ID: 12571527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.
    Welles SL; Pitt J; Colgrove R; McIntosh K; Chung PH; Colson A; Lockman S; Fowler MG; Hanson C; Landesman S; Moye J; Rich KC; Zorrilla C; Japour AJ
    AIDS; 2000 Feb; 14(3):263-71. PubMed ID: 10716502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines.
    Read P; Costelloe S; Mullen J; O'Shea S; Lyons F; Hay P; Welch J; Larbalestier N; Taylor G; de Ruiter A
    HIV Med; 2008 Aug; 9(7):448-51. PubMed ID: 18840150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.
    Mandelbrot L; Landreau-Mascaro A; Rekacewicz C; Berrebi A; Bénifla JL; Burgard M; Lachassine E; Barret B; Chaix ML; Bongain A; Ciraru-Vigneron N; Crenn-Hébert C; Delfraissy JF; Rouzioux C; Mayaux MJ; Blanche S;
    JAMA; 2001 Apr; 285(16):2083-93. PubMed ID: 11311097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission.
    Olson SC; Ngo-Giang-Huong N; Beck I; Deng W; Britto P; Shapiro DE; Bumgarner RE; Mullins JI; Van Dyke RB; Jourdain G; Frenkel LM
    AIDS; 2015 Jul; 29(12):1467-71. PubMed ID: 26244386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission.
    Giuliano M; Palmisano L; Galluzzo CM; Amici R; Germinario E; Okong P; Kituuka P; Mmirro F; Magoni M; Vella S
    AIDS; 2003 Jul; 17(10):1570-2. PubMed ID: 12824800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
    Bassetti D; Cargnel A
    Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral load and perinatal transmission.
    Sax PE
    AIDS Clin Care; 1999 Oct; 11(10):84. PubMed ID: 11366707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.
    Kuhn L; Sinkala M; Kankasa MP; Kasonde P; Thea DM; Aldrovandi GM
    J Acquir Immune Defic Syndr; 2006 Jun; 42(2):260-2. PubMed ID: 16760802
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy.
    Clarke JR; Braganza R; Mirza A; Stainsby C; Ait-Khaled M; Wright A; Lyall H; Parker D; McClure MO; Weber JN; Taylor GP
    J Med Virol; 1999 Nov; 59(3):364-8. PubMed ID: 10502270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load.
    Wolffers I
    Lancet; 1999 Jul; 354(9173):158. PubMed ID: 10408507
    [No Abstract]   [Full Text] [Related]  

  • 15. Perinatal transmission of HIV-1.
    Wood L
    JAMA; 1996 Oct 23-30; 276(16):1300-1; author reply 1301. PubMed ID: 8861985
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zidovudine resistance phenotype and risk of perinatal HIV-1 transmission in zidovudine monotherapy-treated mothers with moderately advanced disease.
    Bauer GR; Welles SL; Colgrove RR; Pitt J;
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):312-9. PubMed ID: 14600578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
    Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
    Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zidovudine treatment prevents vertical transmission of human immunodeficiency virus-1 independently of viral load.
    Alonso Arias R; Gurbindo MD; Miralles P; Segovia P; Fernández-Cruz E; Muñoz-Fernández MA
    Acta Paediatr; 1998 Nov; 87(11):1208-9. PubMed ID: 9846929
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing perinatal HIV transmission: zidovudine use during pregnancy.
    Carmichael C
    Am Fam Physician; 1997 Jan; 55(1):171-4, 177-8. PubMed ID: 9012276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.